Log In
BCIQ
Print this Print this
 

MOTI1001

  Manage Alerts
Collapse Summary General Information
Company BioMoti Ltd.
DescriptionPaclitaxel-loaded biodegradable microparticles surface-modified with Fas receptor (CD95) protein
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today